100 related articles for article (PubMed ID: 29428525)
1. Synthesis and activity evaluation of a series of cholanamides as modulators of the liver X receptors.
Martínez MD; Ghini AA; Dansey MV; Veleiro AS; Pecci A; Alvarez LD; Burton G
Bioorg Med Chem; 2018 Mar; 26(5):1092-1101. PubMed ID: 29428525
[TBL] [Abstract][Full Text] [Related]
2. In search for novel liver X receptors modulators by extending the structure-activity relationships of cholenamide derivatives.
Pontini L; Palazzoli P; Maggioni D; Damiano G; Giorgi G; Russo V; Marinozzi M
Chem Phys Lipids; 2021 Nov; 241():105151. PubMed ID: 34673009
[TBL] [Abstract][Full Text] [Related]
3. Fluorinated oxysterol analogues: Synthesis, molecular modelling and LXRβ activity.
Rodriguez CR; Alvarez LD; Dansey MV; Paolo LS; Veleiro AS; Pecci A; Burton G
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):268-276. PubMed ID: 27452335
[TBL] [Abstract][Full Text] [Related]
4. Synthetic LXR agonist suppresses endogenous cholesterol biosynthesis and efficiently lowers plasma cholesterol.
Pfeifer T; Buchebner M; Chandak PG; Patankar J; Kratzer A; Obrowsky S; Rechberger GN; Kadam RS; Kompella UB; Kostner GM; Kratky D; Levak-Frank S
Curr Pharm Biotechnol; 2011 Feb; 12(2):285-92. PubMed ID: 21190543
[TBL] [Abstract][Full Text] [Related]
5. Selective LXR agonist DMHCA corrects retinal and bone marrow dysfunction in type 2 diabetes.
Vieira CP; Fortmann SD; Hossain M; Longhini AL; Hammer SS; Asare-Bediako B; Crossman DK; Sielski MS; Adu-Agyeiwaah Y; Dupont M; Floyd JL; Li Calzi S; Lydic T; Welner RS; Blanchard GJ; Busik JV; Grant MB
JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32641586
[TBL] [Abstract][Full Text] [Related]
6. Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype.
Lund EG; Peterson LB; Adams AD; Lam MH; Burton CA; Chin J; Guo Q; Huang S; Latham M; Lopez JC; Menke JG; Milot DP; Mitnaul LJ; Rex-Rabe SE; Rosa RL; Tian JY; Wright SD; Sparrow CP
Biochem Pharmacol; 2006 Feb; 71(4):453-63. PubMed ID: 16325781
[TBL] [Abstract][Full Text] [Related]
7. Development of Tetrachlorophthalimides as Liver X Receptor β (LXRβ)-Selective Agonists.
Nomura S; Endo-Umeda K; Makishima M; Hashimoto Y; Ishikawa M
ChemMedChem; 2016 Oct; 11(20):2347-2360. PubMed ID: 27690261
[TBL] [Abstract][Full Text] [Related]
8. C24-hydroxylated stigmastane derivatives as Liver X Receptor agonists.
Castro Navas FF; Giorgi G; Maggioni D; Pacciarini M; Russo V; Marinozzi M
Chem Phys Lipids; 2018 May; 212():44-50. PubMed ID: 29352964
[TBL] [Abstract][Full Text] [Related]
9. Cholestenoic acid analogues as inverse agonists of the liver X receptors.
Alvarez LD; Dansey MV; Ogara MF; Peña CI; Houtman R; Veleiro AS; Pecci A; Burton G
J Steroid Biochem Mol Biol; 2020 May; 199():105585. PubMed ID: 31931135
[TBL] [Abstract][Full Text] [Related]
10. Structurally Selective Mechanism of Liver X Receptor Ligand:
Ding P; Chen Z; Chen H; Zhang Z; Liu Z; Yan X; Zhou H; Gu Q; Li C; Xu J
J Chem Inf Model; 2019 Jul; 59(7):3277-3290. PubMed ID: 31192592
[TBL] [Abstract][Full Text] [Related]
11. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
12. Structure-based virtual screening for identification of potential non-steroidal LXR modulators against neurodegenerative conditions.
Deshwal S; Baidya AT; Kumar R; Sandhir R
J Steroid Biochem Mol Biol; 2022 Oct; 223():106150. PubMed ID: 35787453
[TBL] [Abstract][Full Text] [Related]
13. Liver X Receptors and their Agonists: Targeting for Cholesterol Homeostasis and Cardiovascular Diseases.
Ma Z; Deng C; Hu W; Zhou J; Fan C; Di S; Liu D; Yang Y; Wang D
Curr Issues Mol Biol; 2017; 22():41-64. PubMed ID: 27669666
[TBL] [Abstract][Full Text] [Related]
14. Liver X receptors interact with corepressors to regulate gene expression.
Hu X; Li S; Wu J; Xia C; Lala DS
Mol Endocrinol; 2003 Jun; 17(6):1019-26. PubMed ID: 12663743
[TBL] [Abstract][Full Text] [Related]
15. Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
Jia Y; Hoang MH; Jun HJ; Lee JH; Lee SJ
Bioorg Med Chem Lett; 2013 Jul; 23(14):4185-90. PubMed ID: 23769638
[TBL] [Abstract][Full Text] [Related]
16. Identfication of Potent LXRβ-Selective Agonists without LXRα Activation by In Silico Approaches.
Chen M; Yang F; Kang J; Gan H; Yang X; Lai X; Gao Y
Molecules; 2018 Jun; 23(6):. PubMed ID: 29867043
[TBL] [Abstract][Full Text] [Related]
17. Destabilization of the torsioned conformation of a ligand side chain inverts the LXRβ activity.
Álvarez LD; Dansey MV; Grinman DY; Navalesi D; Samaja GA; Del Fueyo MC; Bastiaensen N; Houtman R; Estrin DA; Veleiro AS; Pecci A; Burton G
Biochim Biophys Acta; 2015 Dec; 1851(12):1577-86. PubMed ID: 26434697
[TBL] [Abstract][Full Text] [Related]
18.
El-Darzi N; Astafev A; Mast N; Saadane A; Lam M; Pikuleva IA
Front Pharmacol; 2018; 9():827. PubMed ID: 30090064
[No Abstract] [Full Text] [Related]
19. Recent Advances in the Medicinal Chemistry of Liver X Receptors.
El-Gendy BEM; Goher SS; Hegazy LS; Arief MMH; Burris TP
J Med Chem; 2018 Dec; 61(24):10935-10956. PubMed ID: 30004226
[TBL] [Abstract][Full Text] [Related]
20. LXRβ activation increases intestinal cholesterol absorption, leading to an atherogenic lipoprotein profile.
Hu X; Steffensen KR; Jiang ZY; Parini P; Gustafsson JÅ; Gåfvels M; Eggertsen G
J Intern Med; 2012 Nov; 272(5):452-64. PubMed ID: 22329358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
